hit counter
Bayer (BAYRY) Stock News Sentiment & Price - Sentifly
BAYRY - Sentifly


Profile

Watchlist

Your watchlist is empty. Go add some tickers to it!



Bayer (BAYRY)

BAYRY Price and Sentiment
1MO
1D
Positive, Negative
Loading chart...
BAYRY Latest news
Reuters
Neutral
Bayer sees no guidance hit from hurricane, planting trends
2021-10-19 09:39

Bayer sees no impact on its full-year guidance from customers' changing planting habits or a five-week shutdown at its main glyphosate production site in Louisiana after Hurricane Ida, the German life science group said on Tuesday.

Reuters
Negative
Bayer blasts 'unscientific' rejection by Mexican regulator of GMO corn permit
2021-10-08 16:43

Bayer is evaluating its legal options after Mexican health regulators for the first time rejected a GMO corn permit it was seeking, the German pharmaceutical and crop science giant said in a statement to Reuters on Friday, blasting the decision as "non-scientific."

Reuters
Negative
Corteva faces slow start as it takes aim at Bayer's Brazil soy reign
2021-10-08 07:05

U.S. pesticide and seed maker Corteva Inc will take up to three times longer to break into Brazil's genetically modified soy seed market than it did in the United States, where Corteva's sales grew rapidly in recent years, the company said.

Reuters
Positive
Bayer shares up after first trial win over Roundup
2021-10-06 01:52

Shares in Bayer AG rose 2.5% in pre-market trade on Wednesday after the German agricultural and pharmaceuticals firm won its first trial over claims its Roundup weedkiller causes cancer.

Reuters
Positive
Bayer wins its first Roundup jury verdict in case of child's cancer
2021-10-05 19:09

Bayer AG won its first trial over claims its Roundup weedkiller causes cancer after a California jury found that the herbicide was not a substantial cause of a child's rare form of non-Hodgkin's lymphoma, the company said on Tuesday.

Business Wire
Neutral
Bayer Appoints New General Managers for Nutritionals and Digestive Health Businesses
2021-10-05 10:00

WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer Consumer Health has appointed new General Managers to lead its Nutritionals and Digestive Health businesses, two of its fastest growing categories. After 16 years at Bayer, Lisa Perez is being named General Manager and Vice President Marketing – Nutritionals. In addition, David Ball has been appointed General Manager and Vice President Marketing – Digestive Health. Perez and Ball will start these new roles on November 1. Perez currently serves as Senior Di

GuruFocus
Neutral
Bayer Getting Past Litigation of Roundup
2021-09-28 14:36

German blue-chip Bayer AG ( BAYRY , Financial) has really gotten beaten up with its multibillion-dollar litigation payouts of Roundup. The stock is at a multiyear low, but it looks like the litigation issues will come to and end.

Benzinga
Positive
BWXT Medical, Bayer AG Ink Agreement On Actinium-225
2021-09-16 10:24

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com Trending

Business Wire
Neutral
Bayer Announces Recipients of the Second Annual Pulmonary Hypertension Accelerated Awards
2021-09-10 08:00

WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer announced the 2020 recipients of the annual Pulmonary Hypertension Accelerated Bayer (PHAB) Awards, a U.S.-based research grant program created to support clinical research in pulmonary hypertension (PH), with a focus on pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). The seven recipients will receive a combined total of $1 million in grants over a two-year period, making the PHAB Awards one of the largest i

Business Wire
Neutral
Bayer to Highlight Expanded Research from Growing Oncology Portfolio at ESMO Congress 2021
2021-09-09 08:00

WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer will present new investigational data from its established portfolio of approved oncology therapies at the upcoming ESMO Congress 2021 from September 16-21, 2021. Presentations will center around Bayer's ongoing focus in addressing patient needs through expanded research with existing therapies in certain cancers, as well as studies in new tumor types and in combination with other therapies. Among the featured research presented will be three subset analys

Loading more news...